Digital Therapeutics Market Size, Share, and Trends 2025 to 2034

The global digital therapeutics market size is calculated at USD 9.73 billion in 2025 and is forecasted to reach around USD 56.76 billion by 2034, accelerating at a CAGR of 21.65% from 2025 to 2034. The North America digital therapeutics market size surpassed USD 3.46 billion in 2024 and is expanding at a CAGR of 21.36% during the forecast period. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.

Last Updated : May 2025  |  Report Code : 1128  |  Category : Healthcare  |  Format : PDF / PPT / Excel
cart   Get a Sample     cart    Report Description

List of Contents

Digital Therapeutics Market

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology (Premium Insights)

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Digital Therapeutics Market 

5.1. COVID-19 Landscape: Digital Therapeutics Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Digital Therapeutics Market, By Product Type

8.1. Digital Therapeutics Market, by Product Type

8.1.1. Prescription Digital Therapeutics (PDTs)

8.1.1.1. Market Revenue and Forecast

8.1.2. Prescription Digital Therapeutics (PDTs)

8.1.2.1. Market Revenue and Forecast

8.1.3. Digital Companions (for Rx drugs)

8.1.3.1. Market Revenue and Forecast

8.1.4. Remote Monitoring Tools / Digital Biomarkers

8.1.4.1. Market Revenue and Forecast

8.1.5. Behavioral & Cognitive Interventions via Digital Platforms

8.1.5.1. Market Revenue and Forecast

8.1.6. Mobile Health (mHealth) Applications

8.1.6.1. Market Revenue and Forecast

8.1.7. Virtual Coaching & Adherence Tools

8.1.7.1. Market Revenue and Forecast

Chapter 9. Global Digital Therapeutics Market, By Therapy Area

9.1. Digital Therapeutics Market, by Therapy Area

9.1.1. Central Nervous System (CNS) / Neuroscience

9.1.1.1. Market Revenue and Forecast

9.1.2. Gastrointestinal Disorders (GI)

9.1.2.1. Market Revenue and Forecast

9.1.3. Metabolic and Endocrine

9.1.3.1. Market Revenue and Forecast

9.1.4. Oncology (Supportive care DTx)

9.1.4.1. Market Revenue and Forecast

9.1.5. Rare Diseases (Support & Monitoring)

9.1.5.1. Market Revenue and Forecast

9.1.6. Other Areas

9.1.6.1. Market Revenue and Forecast

Chapter 10. Global Digital Therapeutics Market, By Delivery Platform 

10.1. Digital Therapeutics Market, by Delivery Platform

10.1.1. Mobile Applications (iOS, Android)

10.1.1.1. Market Revenue and Forecast

10.1.2. Web-based Platforms / Portals

10.1.2.1. Market Revenue and Forecast

10.1.3. Smart Wearables

10.1.3.1. Market Revenue and Forecast

10.1.4. VR/AR-based Interventions

10.1.4.1. Market Revenue and Forecast

10.1.5. Connected Medical Devices (e.g., digital inhalers, glucose monitors)

10.1.5.1. Market Revenue and Forecast

10.1.6. AI-based Chatbots or Coaching Interfaces

10.1.6.1. Market Revenue and Forecast

Chapter 11. Global Digital Therapeutics Market, By Business Model

11.1. Digital Therapeutics Market, by Business Model

11.1.1. B2B2C

11.1.1.1. Market Revenue and Forecast

11.1.2. Direct-to-Consumer (D2C)

11.1.2.1. Market Revenue and Forecast

11.1.3. Pharma-DTx Partnerships (Companion DTx or Co-commercialization)

11.1.3.1. Market Revenue and Forecast

11.1.4. Reimbursement-based (Formulary inclusion, CMS approvals)

11.1.4.1. Market Revenue and Forecast

11.1.5. Employer Health Programs

11.1.5.1. Market Revenue and Forecast

Chapter 12. Global Digital Therapeutics Market, By End User

12.1. Digital Therapeutics Market, by End User

12.1.1. Patients

12.1.1.1. Market Revenue and Forecast

12.1.2. Healthcare Providers

12.1.2.1. Market Revenue and Forecast

12.1.3. Payers

12.1.3.1. Market Revenue and Forecast

12.1.4. Pharmaceutical Companies

12.1.4.1. Market Revenue and Forecast

Chapter 13. Global Digital Therapeutics Market, Regional Estimates and Trend Forecast

13.1. North America

13.1.1. Market Revenue and Forecast, by Product Type

13.1.2. Market Revenue and Forecast, by Therapy Area

13.1.3. Market Revenue and Forecast, by Delivery Platform

13.1.4. Market Revenue and Forecast, by Business Model

13.1.5. Market Revenue and Forecast, by End User

13.1.6. U.S.

13.1.6.1. Market Revenue and Forecast, by Product Type

13.1.6.2. Market Revenue and Forecast, by Therapy Area

13.1.6.3. Market Revenue and Forecast, by Delivery Platform

13.1.6.4. Market Revenue and Forecast, by Business Model

13.1.6.5. Market Revenue and Forecast, by End User  

13.1.7. Rest of North America

13.1.7.1. Market Revenue and Forecast, by Product Type

13.1.7.2. Market Revenue and Forecast, by Therapy Area

13.1.7.3. Market Revenue and Forecast, by Delivery Platform

13.1.7.4. Market Revenue and Forecast, by Business Model

13.1.7.5. Market Revenue and Forecast, by End User

13.2. Europe

13.2.1. Market Revenue and Forecast, by Product Type

13.2.2. Market Revenue and Forecast, by Therapy Area

13.2.3. Market Revenue and Forecast, by Delivery Platform

13.2.4. Market Revenue and Forecast, by Business Model  

13.2.5. Market Revenue and Forecast, by End User  

13.2.6. UK

13.2.6.1. Market Revenue and Forecast, by Product Type

13.2.6.2. Market Revenue and Forecast, by Therapy Area

13.2.6.3. Market Revenue and Forecast, by Delivery Platform

13.2.7. Market Revenue and Forecast, by Business Model  

13.2.8. Market Revenue and Forecast, by End User  

13.2.9. Germany

13.2.9.1. Market Revenue and Forecast, by Product Type

13.2.9.2. Market Revenue and Forecast, by Therapy Area

13.2.9.3. Market Revenue and Forecast, by Delivery Platform

13.2.10. Market Revenue and Forecast, by Business Model

13.2.11. Market Revenue and Forecast, by End User

13.2.12. France

13.2.12.1. Market Revenue and Forecast, by Product Type

13.2.12.2. Market Revenue and Forecast, by Therapy Area

13.2.12.3. Market Revenue and Forecast, by Delivery Platform

13.2.12.4. Market Revenue and Forecast, by Business Model

13.2.13. Market Revenue and Forecast, by End User

13.2.14. Rest of Europe

13.2.14.1. Market Revenue and Forecast, by Product Type

13.2.14.2. Market Revenue and Forecast, by Therapy Area

13.2.14.3. Market Revenue and Forecast, by Delivery Platform

13.2.14.4. Market Revenue and Forecast, by Business Model

13.2.15. Market Revenue and Forecast, by End User

13.3. APAC

13.3.1. Market Revenue and Forecast, by Product Type

13.3.2. Market Revenue and Forecast, by Therapy Area

13.3.3. Market Revenue and Forecast, by Delivery Platform

13.3.4. Market Revenue and Forecast, by Business Model

13.3.5. Market Revenue and Forecast, by End User

13.3.6. India

13.3.6.1. Market Revenue and Forecast, by Product Type

13.3.6.2. Market Revenue and Forecast, by Therapy Area

13.3.6.3. Market Revenue and Forecast, by Delivery Platform

13.3.6.4. Market Revenue and Forecast, by Business Model

13.3.7. Market Revenue and Forecast, by End User

13.3.8. China

13.3.8.1. Market Revenue and Forecast, by Product Type

13.3.8.2. Market Revenue and Forecast, by Therapy Area

13.3.8.3. Market Revenue and Forecast, by Delivery Platform

13.3.8.4. Market Revenue and Forecast, by Business Model

13.3.9. Market Revenue and Forecast, by End User

13.3.10. Japan

13.3.10.1. Market Revenue and Forecast, by Product Type

13.3.10.2. Market Revenue and Forecast, by Therapy Area

13.3.10.3. Market Revenue and Forecast, by Delivery Platform

13.3.10.4. Market Revenue and Forecast, by Business Model

13.3.10.5. Market Revenue and Forecast, by End User

13.3.11. Rest of APAC

13.3.11.1. Market Revenue and Forecast, by Product Type

13.3.11.2. Market Revenue and Forecast, by Therapy Area

13.3.11.3. Market Revenue and Forecast, by Delivery Platform

13.3.11.4. Market Revenue and Forecast, by Business Model

13.3.11.5. Market Revenue and Forecast, by End User

13.4. MEA

13.4.1. Market Revenue and Forecast, by Product Type

13.4.2. Market Revenue and Forecast, by Therapy Area

13.4.3. Market Revenue and Forecast, by Delivery Platform

13.4.4. Market Revenue and Forecast, by Business Model

13.4.5. Market Revenue and Forecast, by End User

13.4.6. GCC

13.4.6.1. Market Revenue and Forecast, by Product Type

13.4.6.2. Market Revenue and Forecast, by Therapy Area

13.4.6.3. Market Revenue and Forecast, by Delivery Platform

13.4.6.4. Market Revenue and Forecast, by Business Model

13.4.7. Market Revenue and Forecast, by End User

13.4.8. North Africa

13.4.8.1. Market Revenue and Forecast, by Product Type

13.4.8.2. Market Revenue and Forecast, by Therapy Area

13.4.8.3. Market Revenue and Forecast, by Delivery Platform

13.4.8.4. Market Revenue and Forecast, by Business Model

13.4.9. Market Revenue and Forecast, by End User

13.4.10. South Africa

13.4.10.1. Market Revenue and Forecast, by Product Type

13.4.10.2. Market Revenue and Forecast, by Therapy Area

13.4.10.3. Market Revenue and Forecast, by Delivery Platform

13.4.10.4. Market Revenue and Forecast, by Business Model

13.4.10.5. Market Revenue and Forecast, by End User

13.4.11. Rest of MEA

13.4.11.1. Market Revenue and Forecast, by Product Type

13.4.11.2. Market Revenue and Forecast, by Therapy Area

13.4.11.3. Market Revenue and Forecast, by Delivery Platform

13.4.11.4. Market Revenue and Forecast, by Business Model

13.4.11.5. Market Revenue and Forecast, by End User

13.5. Latin America

13.5.1. Market Revenue and Forecast, by Product Type

13.5.2. Market Revenue and Forecast, by Therapy Area

13.5.3. Market Revenue and Forecast, by Delivery Platform

13.5.4. Market Revenue and Forecast, by Business Model

13.5.5. Market Revenue and Forecast, by End User

13.5.6. Brazil

13.5.6.1. Market Revenue and Forecast, by Product Type

13.5.6.2. Market Revenue and Forecast, by Therapy Area

13.5.6.3. Market Revenue and Forecast, by Delivery Platform

13.5.6.4. Market Revenue and Forecast, by Business Model

13.5.7. Market Revenue and Forecast, by End User

13.5.8. Rest of LATAM

13.5.8.1. Market Revenue and Forecast, by Product Type

13.5.8.2. Market Revenue and Forecast, by Therapy Area

13.5.8.3. Market Revenue and Forecast, by Delivery Platform

13.5.8.4. Market Revenue and Forecast, by Business Model

13.5.8.5. Market Revenue and Forecast, by End User

Chapter 14. Company Profiles

14.1. Fitbit Health Solutions

14.1.1. Company Overview

14.1.2. Product Offerings

14.1.3. Financial Performance

14.1.4. Recent Initiatives

14.2. 2MORROW, Inc.

14.2.1. Company Overview

14.2.2. Product Offerings

14.2.3. Financial Performance

14.2.4. Recent Initiatives

14.3. 2MORROW, Inc.

14.3.1. Company Overview

14.3.2. Product Offerings

14.3.3. Financial Performance

14.3.4. Recent Initiatives

14.4. Livongo Health, Inc.

14.4.1. Company Overview

14.4.2. Product Offerings

14.4.3. Financial Performance

14.4.4. Recent Initiatives

14.5. Pear Therapeutics, Inc.

14.5.1. Company Overview

14.5.2. Product Offerings

14.5.3. Financial Performance

14.5.4. Recent Initiatives

14.6. Omada Health, Inc.

14.6.1. Company Overview

14.6.2. Product Offerings

14.6.3. Financial Performance

14.6.4. Recent Initiatives

14.7. Omada Health, Inc.

14.7.1. Company Overview

14.7.2. Product Offerings

14.7.3. Financial Performance

14.7.4. Recent Initiatives

14.8. Omada Health, Inc.

14.8.1. Company Overview

14.8.2. Product Offerings

14.8.3. Financial Performance

14.8.4. Recent Initiatives

14.9. Welldoc, Inc.

14.9.1. Company Overview

14.9.2. Product Offerings

14.9.3. Financial Performance

14.9.4. Recent Initiatives

14.10. Voluntis, Inc.

14.10.1. Company Overview

14.10.2. Product Offerings

14.10.3. Financial Performance

14.10.4. Recent Initiatives

Chapter 15. Research Methodology

15.1. Primary Research

15.2. Secondary Research

15.3. Assumptions

Chapter 16. Appendix

16.1. About Us

16.2. Glossary of Terms

For questions or customization requests, please reach out to us at sales@precedenceresearch.com

Frequently Asked Questions

The digital therapeutics market was valued at USD 7.88 billion in 2024 and is expected to reach USD 56.76 billion by 2034.

The global digital therapeutics market is growing at a compound annual growth rate (CAGR) of 21.83% during the forecast period 2025 to 2034.

North America captured the largest market share in the global digital therapeutics market and expected to retain its position over the upcoming years.

The Asia Pacific exhibits the fastest growth rate during the forthcoming years. The significant growth of the region is mainly due to rapid urbanization and fast changing technology landscape in the region.

Software segment captured the largest value share based on product type for the year 2024 and projected to register the fastest growth over the analysis timeframe.

Based on application, diabetes dominated the global market in 2024 and estimated to forecast same trend over the upcoming period due to rising prevalence of diabetes across the globe.

Some of the key players operating in the market are Fitbit Health Solutions, 2MORROW, Inc., Medtronic Plc., Livongo Health, Inc., Pear Therapeutics, Inc., Omada Health, Inc., Resmed, Inc. (Propeller Health), Proteus Digital Health, Inc., Welldoc, Inc.,Voluntis, Inc., Canary Health Inc., Noom, Inc., Mango Health Inc., and Dthera Sciences among others.

Increasing penetration of digital healthcare applications & platforms because of rapid adoption of smartphones & tablets expected to spur the market growth over the upcoming years. Rising prevalence of chronic diseases coupled with increasing need to regulate the escalating cost of healthcare facilities is likely to impel the market growth. Further, constantly changing digital platform in various sectors has grappled consumers towards using of these digital platforms as well as increasing awareness pertaining to health and fitness are the primary factors that boost the market growth over the forthcoming timeframe.

Proceed To Buy

USD 4900
USD 3800
USD 2100
USD 2100
Immediate Delivery Available

Plan your call and get expert insights!

Schedule a Meeting Schedule a Meeting

Ask For Sample

No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client

down-arrow-imgGet a Sample

Connect with us now; your solution awaits on the other side!

Contact Us